[DPHARMA] QoQ Annualized Quarter Result on 31-Dec-2020 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-Feb-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
QoQ- 3.63%
YoY- 6.04%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 658,308 643,786 665,816 569,902 581,088 604,088 634,852 2.44%
PBT 87,808 86,746 92,704 76,157 74,248 74,236 70,908 15.30%
Tax -21,185 -20,738 -22,248 -17,547 -17,692 -17,656 -16,664 17.33%
NP 66,622 66,008 70,456 58,610 56,556 56,580 54,244 14.67%
-
NP to SH 66,622 66,008 70,456 58,610 56,556 56,580 54,244 14.67%
-
Tax Rate 24.13% 23.91% 24.00% 23.04% 23.83% 23.78% 23.50% -
Total Cost 591,685 577,778 595,360 511,292 524,532 547,508 580,608 1.26%
-
Net Worth 612,147 614,350 635,424 642,484 584,565 581,725 540,662 8.62%
Dividend
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Div 6,278 7,061 - 45,891 4,639 6,843 - -
Div Payout % 9.42% 10.70% - 78.30% 8.20% 12.10% - -
Equity
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Net Worth 612,147 614,350 635,424 642,484 584,565 581,725 540,662 8.62%
NOSH 941,765 706,330 706,026 706,026 706,026 684,383 684,383 23.69%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 10.12% 10.25% 10.58% 10.28% 9.73% 9.37% 8.54% -
ROE 10.88% 10.74% 11.09% 9.12% 9.67% 9.73% 10.03% -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 69.90 91.17 94.30 80.72 83.50 88.27 92.76 -17.17%
EPS 7.08 9.34 9.96 8.46 8.21 8.26 7.92 -7.19%
DPS 0.67 1.00 0.00 6.50 0.67 1.00 0.00 -
NAPS 0.65 0.87 0.90 0.91 0.84 0.85 0.79 -12.18%
Adjusted Per Share Value based on latest NOSH - 706,026
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 68.38 66.88 69.16 59.20 60.36 62.75 65.95 2.43%
EPS 6.92 6.86 7.32 6.09 5.88 5.88 5.63 14.73%
DPS 0.65 0.73 0.00 4.77 0.48 0.71 0.00 -
NAPS 0.6359 0.6382 0.6601 0.6674 0.6072 0.6043 0.5616 8.62%
Price Multiplier on Financial Quarter End Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 -
Price 1.81 3.03 2.75 3.38 3.16 1.62 1.39 -
P/RPS 2.59 3.32 2.92 4.19 3.78 1.84 1.50 43.87%
P/EPS 25.59 32.41 27.56 40.72 38.88 19.60 17.54 28.60%
EY 3.91 3.09 3.63 2.46 2.57 5.10 5.70 -22.20%
DY 0.37 0.33 0.00 1.92 0.21 0.62 0.00 -
P/NAPS 2.78 3.48 3.06 3.71 3.76 1.91 1.76 35.59%
Price Multiplier on Announcement Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 18/11/21 17/08/21 03/05/21 22/02/21 12/11/20 13/08/20 18/05/20 -
Price 1.62 2.49 2.93 3.42 4.04 3.15 1.72 -
P/RPS 2.32 2.73 3.11 4.24 4.84 3.57 1.85 16.27%
P/EPS 22.90 26.64 29.36 41.20 49.71 38.10 21.70 3.65%
EY 4.37 3.75 3.41 2.43 2.01 2.62 4.61 -3.49%
DY 0.41 0.40 0.00 1.90 0.17 0.32 0.00 -
P/NAPS 2.49 2.86 3.26 3.76 4.81 3.71 2.18 9.25%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment